📊 Score Breakdown
Offering Ability
40
Cash Runway
0
Float Risk
30
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for ELVN.
💹 Market Data
Market Cap$2.41B
Shares Outstanding60.90M
Float44.42M
Cash$452.40M
Debt$302.0K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 5.3% shares (2025Q4 vs prior)
130 institutional holders · 63.15M shares
#1
ORBIMED ADVISORS LLC
7.96M shares
#2
FMR LLC
7.11M shares
#3
Commodore Capital LP
4.69M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest5.12M
Days to Cover8.1
% of Float11.5%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2023
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for ELVN
📊 ELVN FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 ELVN Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.